These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 7783910)

  • 1. Inhibitory cytokines and cytokine inhibitors.
    Burger D; Dayer JM
    Neurology; 1995 Jun; 45(6 Suppl 6):S39-43. PubMed ID: 7783910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relative cytokine and cytokine inhibitor production by mononuclear cells and neutrophils.
    Xing L; Remick DG
    Shock; 2003 Jul; 20(1):10-6. PubMed ID: 12813362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokines and soluble cytokine receptors in pleural effusions from septic and nonseptic patients.
    Marie C; Losser MR; Fitting C; Kermarrec N; Payen D; Cavaillon JM
    Am J Respir Crit Care Med; 1997 Nov; 156(5):1515-22. PubMed ID: 9372669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokine inhibitors in autoimmune disease.
    Weckmann AL; Alcocer-Varela J
    Semin Arthritis Rheum; 1996 Oct; 26(2):539-57. PubMed ID: 8916298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Balance between proinflammatory cytokines and their inhibitors in bronchial lavage from patients with status asthmaticus.
    Tillie-Leblond I; Pugin J; Marquette CH; Lamblin C; Saulnier F; Brichet A; Wallaert B; Tonnel AB; Gosset P
    Am J Respir Crit Care Med; 1999 Feb; 159(2):487-94. PubMed ID: 9927362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased secretion of pro-inflammatory cytokines by circulating polymorphonuclear neutrophils and regulation by interleukin 10 during intestinal inflammation.
    Nikolaus S; Bauditz J; Gionchetti P; Witt C; Lochs H; Schreiber S
    Gut; 1998 Apr; 42(4):470-6. PubMed ID: 9616306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppressed alloantigen presentation, increased TNF-alpha, IL-1, IL-1Ra, IL-10, and modulation of TNF-R in UV-irradiated human skin.
    Barr RM; Walker SL; Tsang W; Harrison GI; Ettehadi P; Greaves MW; Young AR
    J Invest Dermatol; 1999 May; 112(5):692-8. PubMed ID: 10233758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokines and anticytokines in the pathogenesis of sepsis.
    van der Poll T; van Deventer SJ
    Infect Dis Clin North Am; 1999 Jun; 13(2):413-26, ix. PubMed ID: 10340175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacodynamics of subcutaneous recombinant human interleukin-10 in healthy volunteers.
    Huhn RD; Radwanski E; Gallo J; Affrime MB; Sabo R; Gonyo G; Monge A; Cutler DL
    Clin Pharmacol Ther; 1997 Aug; 62(2):171-80. PubMed ID: 9284853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-1 receptor antagonist protein inhibits the synthesis of IgE and proinflammatory cytokines by allergen-stimulated mononuclear cells.
    Sim TC; Hilsmeier KA; Reece LM; Grant JA; Alam R
    Am J Respir Cell Mol Biol; 1994 Oct; 11(4):473-9. PubMed ID: 7917315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proinflammatory and anti-inflammatory cytokines as mediators in the pathogenesis of septic shock.
    Dinarello CA
    Chest; 1997 Dec; 112(6 Suppl):321S-329S. PubMed ID: 9400897
    [No Abstract]   [Full Text] [Related]  

  • 12. Differential cytokine response in host defence mechanisms triggered by gram-negative and gram-positive bacteria, and the roles of gabexate mesilate, a synthetic protease inhibitor.
    Iwadou H; Morimoto Y; Iwagaki H; Sinoura S; Chouda Y; Kodama M; Yoshioka T; Saito S; Yagi T; Tanaka N
    J Int Med Res; 2002; 30(2):99-108. PubMed ID: 12025532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imbalances between tumor necrosis factor-alpha and its soluble receptor forms, and interleukin-1beta and interleukin-1 receptor antagonist in BAL fluid of cavitary pulmonary tuberculosis.
    Tsao TC; Hong Jh; Li LF; Hsieh MJ; Liao SK; Chang KS
    Chest; 2000 Jan; 117(1):103-9. PubMed ID: 10631206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Switching off renal inflammation by anti-inflammatory mediators: the facts, the promise and the hope.
    Baud L; Fouqueray B; Bellocq A
    Kidney Int; 1998 May; 53(5):1118-26. PubMed ID: 9573525
    [No Abstract]   [Full Text] [Related]  

  • 15. Biologic control of the tumor necrosis factor and interleukin-1 signaling cascade.
    Stewart RJ; Marsden PA
    Am J Kidney Dis; 1995 Jun; 25(6):954-66. PubMed ID: 7771496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro modulation of cytokine, cytokine inhibitor, and prostaglandin E release from blood mononuclear cells and synovial fibroblasts by antirheumatic drugs.
    Seitz M; Loetscher P; Dewald B; Towbin H; Baggiolini M
    J Rheumatol; 1997 Aug; 24(8):1471-6. PubMed ID: 9263137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Compartmentalisation of cytokines and cytokine inhibitors in ventilator-associated pneumonia.
    Millo JL; Schultz MJ; Williams C; Weverling GJ; Ringrose T; Mackinlay CI; van der Poll T; Garrard CS
    Intensive Care Med; 2004 Jan; 30(1):68-74. PubMed ID: 14634726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The mode of action of cytokine inhibitors.
    Arend WP
    J Rheumatol Suppl; 2002 Sep; 65():16-21. PubMed ID: 12236617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Host-tumor interaction in ovarian cancer. Spontaneous release of tumor necrosis factor and interleukin-1 inhibitors by purified cell populations from human ovarian carcinoma in vitro.
    Burger RA; Grosen EA; Ioli GR; Van Eden ME; Brightbill HD; Gatanaga M; DiSaia PJ; Granger GA; Gatanaga T
    Gynecol Oncol; 1994 Nov; 55(2):294-303. PubMed ID: 7959299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokine neutralizing strategies in experimental sepsis.
    Enayati P; Fong Y
    Prog Clin Biol Res; 1994; 388():295-306. PubMed ID: 7831365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.